Quantum Knight Receives FDA Authorization, Marking Breakthrough in Cryptographic Security
Quantum Knight, a pioneer in quantum-secure encryption and cybersecurity innovation, has reached a major milestone with its flagship cryptosystem CLEAR™ (Cryptographic Layer for Enterprise Access and Resilience) becoming the first standalone encryption solution to receive Authority to Operate (ATO) from the U.S. Food and Drug Administration (FDA) for use in life-critical medical and digital infrastructure.
